Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program
- PMID: 20594110
- DOI: 10.1086/654001
Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program
Abstract
Objective: To evaluate the effects of an active surveillance program for Staphylococcus aureus linked to a decolonization protocol on the incidence of healthcare-associated infection and new nasal colonization due to S. aureus.
Design: Retrospective quasi-experimental study.
Setting: An 18-bed medical intensive care unit at a tertiary care center in Cleveland, Ohio.
Methods: From January 1, 2006, through December 31, 2007, all patients in the medical intensive care unit were screened for S. aureus nasal carriage at admission and weekly thereafter. During the preintervention period, January 1 through September 30, 2006, only surveillance occurred. During the intervention period, January 1 through December 31, 2007, S. aureus carriers received mupirocin intranasally. Beginning in February 2007, carriers also received chlorhexidine gluconate baths.
Results: During the preintervention period, 604 (73.7%) of 819 patients were screened for S. aureus nasal carriage, yielding 248 prevalent carriers (30.3%). During the intervention period, 752 (78.3%) of 960 patients were screened, yielding 276 carriers (28.8%). The incidence of S. aureus carriage decreased from 25 cases in 3,982 patient-days (6.28 cases per 1,000 patient-days) before intervention to 18 cases in 5,415 patient-days (3.32 cases per 1,000 patient-days) (P=.04; relative risk [RR], 0.53 [95% confidence interval {CI}, 0.28-0.97]) and from 9.57 to 4.77 cases per 1,000 at-risk patient-days (P=.02; RR, 0.50 [95% CI, 0.27-0.91]). The incidence of S. aureus hospital-acquired bloodstream infection during the 2 periods was 2.01 and 1.11 cases per 1,000 patient-days, respectively (P=.28). The incidence of S. aureus ventilator-associated pneumonia decreased from 1.51 to 0.18 cases per 1,000 patient-days (P=.03; RR, 0.12 [95% CI, 0.01-0.83]). The total incidence of S. aureus hospital-acquired infection decreased from 3.52 to 1.29 cases per 1,000 patient-days (P=.03; RR, 0.37 [95% CI, 0.14-0.90]).
Conclusions: Active surveillance for S. aureus nasal carriage combined with decolonization was associated with a decreased incidence of S. aureus colonization and hospital-acquired infection.
Comment on
-
From best to good: can we "right-size" approaches to reducing healthcare-associated infections?Infect Control Hosp Epidemiol. 2010 Aug;31(8):784-5. doi: 10.1086/654002. Infect Control Hosp Epidemiol. 2010. PMID: 20594111 No abstract available.
Similar articles
-
Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers.Infect Control Hosp Epidemiol. 2010 Aug;31(8):786-95. doi: 10.1086/654003. Infect Control Hosp Epidemiol. 2010. PMID: 20524852
-
Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.Eur J Med Res. 2007 Jul 26;12(7):284-8. Eur J Med Res. 2007. PMID: 17933699 Clinical Trial.
-
Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.Ann Thorac Surg. 2006 Jun;81(6):2183-8. doi: 10.1016/j.athoracsur.2006.01.009. Ann Thorac Surg. 2006. PMID: 16731151
-
Has decolonization played a central role in the decline in UK methicillin-resistant Staphylococcus aureus transmission? A focus on evidence from intensive care.J Antimicrob Chemother. 2011 Apr;66 Suppl 2:ii41-7. doi: 10.1093/jac/dkq325. Epub 2010 Sep 18. J Antimicrob Chemother. 2011. PMID: 20852273 Review.
-
New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.Ann Pharmacother. 1998 Jan;32(1):S7-16. doi: 10.1177/106002809803200104. Ann Pharmacother. 1998. PMID: 9475834 Review.
Cited by
-
Impact of active screening for methicillin-resistant Staphylococcus aureus (MRSA) and decolonization on MRSA infections, mortality and medical cost: a quasi-experimental study in surgical intensive care unit.Crit Care. 2015 Apr 8;19(1):143. doi: 10.1186/s13054-015-0876-y. Crit Care. 2015. PMID: 25882709 Free PMC article.
-
Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit.Infect Control Hosp Epidemiol. 2015 Jan;36(1):17-27. doi: 10.1017/ice.2014.12. Infect Control Hosp Epidemiol. 2015. PMID: 25627757 Free PMC article.
-
Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis.J Thorac Dis. 2013 Aug;5(4):518-24. doi: 10.3978/j.issn.2072-1439.2013.08.30. J Thorac Dis. 2013. PMID: 23991311 Free PMC article.
-
Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection.Infect Control Hosp Epidemiol. 2014 Mar;35(3):243-50. doi: 10.1086/675292. Epub 2014 Jan 24. Infect Control Hosp Epidemiol. 2014. PMID: 24521588 Free PMC article. Clinical Trial.
-
Impact of daily bathing with chlorhexidine gluconate on ventilator associated pneumonia in intensive care units: a meta-analysis.J Thorac Dis. 2015 Apr;7(4):746-53. doi: 10.3978/j.issn.2072-1439.2015.04.21. J Thorac Dis. 2015. PMID: 25973242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical